Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalini Saxena

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Biomolecular Structure & Dynamics|September 22, 2018
Inhibitor binding studies of <i>Mycobacterium tuberculosis</i> MraY (Rv21 56c): Insights from molecular modeling, docking, and simulation studiesBala Divya Mallavarapu, Maaged Abdullah, Shalini Saxena, et al.
Journal of Molecular Graphics & Modelling|December 10, 2013
Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screeningShalini Saxena, Parthiban Brindha Devi, Vijay Soni, et al.
ACS Macro Letters|May 18, 2022
Packed Colloidal Phases Mediate the Synthesis of Raspberry-Structured Microgel HeteroaggregatesJeffrey C Gaulding, Shalini Saxena, Danielle E Montanari, et al.
Current Topics in Medicinal Chemistry|September 30, 2014
Mycobacterial DNA gyrB inhibitors: Ligand based pharmacophore modelling and in vitro enzyme inhibition studiesShalini Saxena, Janupally Renuka, Variam Ullas Jeankumar, et al.
Bioorganic & Medicinal Chemistry|September 27, 2016
Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosisGanesh Samala, Parthiban Brindha Devi, Shalini Saxena, et al.
Bioorganic & Medicinal Chemistry|February 13, 2016
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitorsGanesh Samala, Parthiban Brindha Devi, Shalini Saxena, et al.
Bioorganic & Medicinal Chemistry|March 14, 2015
Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domainShalini Saxena, Ganesh Samala, Janupally Renuka, et al.
European Journal of Medicinal Chemistry|January 14, 2015
Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitorsShalini Saxena, Ganesh Samala, Jonnalagadda Padma Sridevi, et al.
Thescientificworldjournal|December 25, 2014
Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymesMartin Krátký, Eva Novotná, Shalini Saxena, et al.
Soft Matter|March 18, 2014
Microgel film dynamics modulate cell adhesion behaviorShalini Saxena, Mark W Spears, Hiroaki Yoshida, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Biomolecular Structure & Dynamics|September 22, 2018
Inhibitor binding studies of <i>Mycobacterium tuberculosis</i> MraY (Rv21 56c): Insights from molecular modeling, docking, and simulation studiesBala Divya Mallavarapu, Maaged Abdullah, Shalini Saxena, et al.
Journal of Molecular Graphics & Modelling|December 10, 2013
Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screeningShalini Saxena, Parthiban Brindha Devi, Vijay Soni, et al.
ACS Macro Letters|May 18, 2022
Packed Colloidal Phases Mediate the Synthesis of Raspberry-Structured Microgel HeteroaggregatesJeffrey C Gaulding, Shalini Saxena, Danielle E Montanari, et al.
Current Topics in Medicinal Chemistry|September 30, 2014
Mycobacterial DNA gyrB inhibitors: Ligand based pharmacophore modelling and in vitro enzyme inhibition studiesShalini Saxena, Janupally Renuka, Variam Ullas Jeankumar, et al.
Bioorganic & Medicinal Chemistry|September 27, 2016
Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosisGanesh Samala, Parthiban Brindha Devi, Shalini Saxena, et al.
Bioorganic & Medicinal Chemistry|February 13, 2016
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitorsGanesh Samala, Parthiban Brindha Devi, Shalini Saxena, et al.
Bioorganic & Medicinal Chemistry|March 14, 2015
Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domainShalini Saxena, Ganesh Samala, Janupally Renuka, et al.
European Journal of Medicinal Chemistry|January 14, 2015
Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitorsShalini Saxena, Ganesh Samala, Jonnalagadda Padma Sridevi, et al.
Thescientificworldjournal|December 25, 2014
Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymesMartin Krátký, Eva Novotná, Shalini Saxena, et al.
Soft Matter|March 18, 2014
Microgel film dynamics modulate cell adhesion behaviorShalini Saxena, Mark W Spears, Hiroaki Yoshida, et al.
Pageof 5